ES2056471T3 - Antagonistas irreversibles de la bombesina. - Google Patents

Antagonistas irreversibles de la bombesina.

Info

Publication number
ES2056471T3
ES2056471T3 ES90909646T ES90909646T ES2056471T3 ES 2056471 T3 ES2056471 T3 ES 2056471T3 ES 90909646 T ES90909646 T ES 90909646T ES 90909646 T ES90909646 T ES 90909646T ES 2056471 T3 ES2056471 T3 ES 2056471T3
Authority
ES
Spain
Prior art keywords
leu
clch
gly
valencia
phe
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90909646T
Other languages
English (en)
Inventor
Castiglione Roberto De
Luigia Gozzini
Pierluigi Lucietto
Fabio Corradi
Marina Ciomei
Isabella Molinari
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Farmitalia Carlo Erba SRL
Carlo Erba SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmitalia Carlo Erba SRL, Carlo Erba SpA filed Critical Farmitalia Carlo Erba SRL
Application granted granted Critical
Publication of ES2056471T3 publication Critical patent/ES2056471T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C07K7/086Bombesin; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PEPTIDO DE LA FORMULA (I) EN EL CUAL RS ES UN GRUPO DE LA FORMULA: 4-(CLCH$_{2}$CH$_{2}$)$_{2}$N-C$_{6}$H$_{4}$-CO-, 3-(CLCH$_{2}$CH$_{2}$)$_{2}$N-C$_{6}$H$_{4}$-CO-, CLCH$_{2}$CH$_{2}$NHCO-, CLCH = CH-CO-, BRCH = CH-CO, CH$_{2}$ = CCLCO-, CH$_{2}$CBRCO $_{2}$ CH$_{2}$N(NO)CO-, O CLCH$_{2}$CO-CH(R$_{1}$)NHCO(CH$_{2}$)$_{2}$CO-; A = UN ENLACE DE VALENCIA, O GLY, LEU-GLY, ARG-LEU-GLY, GLN-ARG-LEU-GLY; B = VALENCIA DE ENLACE O ASN O THR; C = GLN O HIS; X = GLY O ALA; Y = VALENCIA DE ENLACE O HIS(R$_{2}$), HIS(R$_{2}$), PHE, PHE, SER, SER, ALA O ALA; T = VALENCIA DE ENLACE O LEU, LEU, PHE O PHE; W ES UN GRUPO DE LA FORMULA: OH, NH$_{2}$, NH(CH$_{2}$)$_{4}$CH$_{3}$, H(CH$_{2}$)$_{2}$C$_{6}$H$_{5}$, MET-R$_{3}$, LEU-R$_{3}$, ILE-R$_{3}$, O NLE-R$_{3}$; R$_{1}$ = H, UNA CADENA ALIFATICA LINEAL O RAMIFICADA TENIENDO DE 1 A 11 ATOMOS DE CARBONO , BENZILO O GRUPO FENILO; R$_{2}$ = H O TOS, DNP O BZL Y R$_{3}$ = NH$_{2}$ , OH, OCH$_{3}$ O NHNH$_{2}$, Y LAS SALES FARMACEUTICAMENTE ACEPTABLES SON ANTAGONISTAS DEL BOMBASI. SE DESCRIBE TAMBIEN SU PREPARACION Y LOS COMPUESTOS FARMACEUTICOS QUE LAS CONTIENEN.
ES90909646T 1989-06-15 1990-06-12 Antagonistas irreversibles de la bombesina. Expired - Lifetime ES2056471T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898913844A GB8913844D0 (en) 1989-06-15 1989-06-15 Irreversible bombesin antagonists

Publications (1)

Publication Number Publication Date
ES2056471T3 true ES2056471T3 (es) 1994-10-01

Family

ID=10658532

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90909646T Expired - Lifetime ES2056471T3 (es) 1989-06-15 1990-06-12 Antagonistas irreversibles de la bombesina.

Country Status (15)

Country Link
EP (2) EP0402852A1 (es)
JP (1) JPH04500371A (es)
KR (1) KR920700223A (es)
AU (1) AU630715B2 (es)
CA (1) CA2034480A1 (es)
DE (1) DE69008674T2 (es)
ES (1) ES2056471T3 (es)
GB (1) GB8913844D0 (es)
HU (1) HUT56118A (es)
IE (1) IE902136A1 (es)
IL (1) IL94692A0 (es)
NZ (1) NZ234011A (es)
PT (1) PT94352A (es)
WO (1) WO1990015819A1 (es)
ZA (1) ZA904591B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU618029B2 (en) * 1987-11-02 1991-12-12 Imperial Chemical Industries Plc Polypeptide compounds
GB8813356D0 (en) * 1988-06-06 1988-07-13 Ici Plc Polypeptide compounds
US8709998B2 (en) 2003-04-22 2014-04-29 Ipsen Pharma S.A.S. Peptide vectors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4423236A (en) * 1980-08-14 1983-12-27 National Foundation For Cancer Research, Inc. 5,6,-0-Isoalkylidene ascorbic acid derivatives
US4331661A (en) * 1980-10-03 1982-05-25 The Salk Institute For Biological Studies Bombesin analogs
AU618029B2 (en) * 1987-11-02 1991-12-12 Imperial Chemical Industries Plc Polypeptide compounds

Also Published As

Publication number Publication date
NZ234011A (en) 1992-11-25
HU905381D0 (en) 1991-06-28
EP0428700B1 (en) 1994-05-04
GB8913844D0 (en) 1989-08-02
EP0402852A1 (en) 1990-12-19
WO1990015819A1 (en) 1990-12-27
ZA904591B (en) 1991-03-27
AU5859690A (en) 1991-01-08
IL94692A0 (en) 1991-04-15
IE902136L (en) 1990-12-15
KR920700223A (ko) 1992-02-19
EP0428700A1 (en) 1991-05-29
DE69008674D1 (de) 1994-06-09
JPH04500371A (ja) 1992-01-23
CA2034480A1 (en) 1990-12-16
PT94352A (pt) 1991-02-08
DE69008674T2 (de) 1994-09-15
AU630715B2 (en) 1992-11-05
HUT56118A (en) 1991-07-29
IE902136A1 (en) 1991-01-02

Similar Documents

Publication Publication Date Title
BG60102B2 (bg) Метод за получаване на 5-флуор-2(((4-циклопропил- метокси-2-пиридинил)метил)тионил)-1н-бензимидазол
FI923619A (fi) Cykliska peptider och deras anvaendning
ES2095283T3 (es) Compuestos peptidicos, procedimiento para su preparacion y composicion farmaceutica que los contiene.
EA199800357A1 (ru) Фармацевтические ангиостатические дипептидные композиции и способы их применения
FR2669336B1 (fr) Nouveaux derives d'oxazolo pyridines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
ES2148254T3 (es) Peptidos antimicrobianos ciclicos y preparacion de los mismos.
ES2061848T3 (es) Compuestos triciclos, procedimientos para su preparacion y composiciones farmaceuticas que los comprenden.
EP0487502A3 (en) Pharmaceutically active aryl-substituted amine derivatives
ES2133295T3 (es) Peptidos ciclicos y su uso.
ES2045189T3 (es) Nuevos agentes anti-arritmicos i.
RU98113920A (ru) Производные олигопептидов, содержащие d-алкилтриптофан и способные активировать высвобождение гормона роста
ES2056471T3 (es) Antagonistas irreversibles de la bombesina.
FI913034A0 (fi) Foerening med magsyrainhiberande effekt och foerfarande foer dess framstaellning.
DE69918098D1 (de) Neue suesstoffzusammensetzungen
DE69932714D1 (de) Suesstoffzusammensetzung
ES2141096T3 (es) Compuestos de cefalosporina y composiciones farmaceuticas de los mismos.
ES2064525T3 (es) Composicion alimenticia para cultivar peces.
ES2117003T3 (es) Derivados oligopeptidicos de hipoxantina dotados de actividad inmunomoduladora, y composiciones farmaceuticas que los contienen.
ATE106244T1 (de) Iontophoresezusammensetzung zur erhöhung der hautkonzentration aktiver wirkstoffe.
NO883520L (no) Fremgangsmaate for fremstilling av et injeksjonspreparat.
ATE109780T1 (de) Heterocyclische verbindungen und antiulkusmittel.
EA200001136A1 (ru) Фунгицидные смеси
TR199801156T2 (xx) 4-Benzoilizoksazoller ve hidroksibenzonitriller i�eren herbisit kompozisyonlar.
ES2052058T3 (es) Composiciones agricolas y horticolas que confieren resistencia a las plantas contra las tensiones producidas por la sal y el agua.
SE9002384D0 (sv) Derivat av baklobshormoner

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 428700

Country of ref document: ES